This website is intended for a health professional readership
1.Selak V, Webster R, Stepien S, et al. Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials. Heart 2019;105:42–48.
2. Selak V, Webster R. Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe? Ther Adv Drug Saf 2018;9(2):157–162.
Practical tips for GPs switching an HFrEF patient to ENTRESTO from an ACEi or ARB
New Zealand Doctor